Overview
Rheumatoid Arthritis is a kind of arthritis that has
specific characteristics that you can learn more about in the Introduction section. Information about
the prevalence of this disease can be found in the Epidemiology section.
Rheumatoid arthritis is believed to be due to genetic and environmental factors. The Pathophysiology section discussed the development of this kind of arthritis.
Rheumatoid Arthritis_Summary
There are patient and environmental risk factors involved in the development of rheumatoid arthritis, and these are enumerated in the Risk Factors section.
Based on the new classification criteria, a patient can be diagnosed with rheumatoid arthritis based on the number and site of involved joints, serological and acute phase reactants abnormalities, and symptom duration. Rheumatoid arthritis may also be classified based on the severity of the disease. A detailed discussion of these points can be viewed in the Classification section.
Rheumatoid arthritis is believed to be due to genetic and environmental factors. The Pathophysiology section discussed the development of this kind of arthritis.
Rheumatoid Arthritis_SummaryThere are patient and environmental risk factors involved in the development of rheumatoid arthritis, and these are enumerated in the Risk Factors section.
Based on the new classification criteria, a patient can be diagnosed with rheumatoid arthritis based on the number and site of involved joints, serological and acute phase reactants abnormalities, and symptom duration. Rheumatoid arthritis may also be classified based on the severity of the disease. A detailed discussion of these points can be viewed in the Classification section.
History and Physical Examination
There are specific clinical signs and symptoms of rheumatoid
arthritis. In general, patients with rheumatoid arthritis present with joint
pain and/or swelling, morning stiffness lasting for ≥1 hour, myalgia, fatigue,
weight loss, low-grade fever, and depression. To know more, see the Clinical Presentation, History and Physical Examination
section.
Diagnosis
The Laboratory Tests and Ancillaries
and Imaging sections discuss what
tests can be done to help with the diagnosis of rheumatoid arthritis.
Systemic diseases and connective tissue syndromes can mimic rheumatoid arthritis and the Differential Diagnosis section has enumerated them.
Systemic diseases and connective tissue syndromes can mimic rheumatoid arthritis and the Differential Diagnosis section has enumerated them.
Management
In the Evaluation
section, Disease Activity Scoring and Clinical Remission are discussed.
The first goal of therapy is to achieve sustained clinical and radiological remission of the disease. The Principles of Therapy section enumerated the other treatment goals and management strategies used for rheumatoid arthritis.
The Pharmacological Therapy section contains an extensive discussion on the treatment options that include the different DMARD medications, drug combination strategies and adjunctive therapies.
Surgery is generally indicated in patients who suffer from an unacceptable level of pain with activity or at rest in patients with severe rheumatoid arthritis after failure of all nonsurgical approaches to rheumatoid arthritis management. Different surgical interventions that can be done to patients that have this indication in managing rheumatoid arthritis are discussed in the Surgery section.
The Lifestyle Modifications (eg exercise, nutrition therapy, weight management) section discussed the ways to help in the management of rheumatoid arthritis.
Educating the patient or caregiver about the disease is also an important aspect in the management of rheumatoid arthritis. Refer to the Patient Education section for further details.
Different non-pharmacological modalities eg physical therapy, occupational therapy, integrative interventions and psychological therapies in managing rheumatoid arthritis are discussed in detail in the Nonpharmacological section.
Disease activity and the toxic effects of drugs used in the management of rheumatoid arthritis should be measured and documented regularly. Information in assessing the effect of therapy, drug toxicity and other factors is in the Monitoring section.
Prognostic factors that may contribute to the poor outcome of the disease can be seen in the Prognosis section.
The first goal of therapy is to achieve sustained clinical and radiological remission of the disease. The Principles of Therapy section enumerated the other treatment goals and management strategies used for rheumatoid arthritis.
The Pharmacological Therapy section contains an extensive discussion on the treatment options that include the different DMARD medications, drug combination strategies and adjunctive therapies.
Surgery is generally indicated in patients who suffer from an unacceptable level of pain with activity or at rest in patients with severe rheumatoid arthritis after failure of all nonsurgical approaches to rheumatoid arthritis management. Different surgical interventions that can be done to patients that have this indication in managing rheumatoid arthritis are discussed in the Surgery section.
The Lifestyle Modifications (eg exercise, nutrition therapy, weight management) section discussed the ways to help in the management of rheumatoid arthritis.
Educating the patient or caregiver about the disease is also an important aspect in the management of rheumatoid arthritis. Refer to the Patient Education section for further details.
Different non-pharmacological modalities eg physical therapy, occupational therapy, integrative interventions and psychological therapies in managing rheumatoid arthritis are discussed in detail in the Nonpharmacological section.
Disease activity and the toxic effects of drugs used in the management of rheumatoid arthritis should be measured and documented regularly. Information in assessing the effect of therapy, drug toxicity and other factors is in the Monitoring section.
Prognostic factors that may contribute to the poor outcome of the disease can be seen in the Prognosis section.
Frequently Asked Questions
What key infectious agents are associated with rheumatoid arthritis etiology?
Several bacterial pathogens, notably Porphyromonas gingivalis from periodontal disease, Helicobacter pylori, and Escherichia coli, along with viral agents such as Epstein-Barr virus, are strongly associated with initiating aberrant immune responses in rheumatoid arthritis. Read more
What clinical signs differentiate early from established rheumatoid arthritis?
Early rheumatoid arthritis is clinically defined by the presence of signs and symptoms for less than six months. In contrast, established disease is characterized by active symptoms persisting for six months or longer, typically presenting with symmetric polyarthritis of the small joints of the hands and feet. Read more
Which diagnostic imaging modalities are preferred for detecting early joint damage?
While conventional X-rays are standard for monitoring long-term bone damage, they often appear normal in early rheumatoid arthritis. Musculoskeletal ultrasound and MRI are highly sensitive modalities preferred for detecting subtle synovial inflammation and bone erosions in the early stages of the disease. Read more
What is the role of conventional synthetic DMARDs in therapy?
Conventional synthetic disease-modifying antirheumatic drugs, such as methotrexate, are the first-line pharmacological treatment. They slow disease progression and prevent irreversible joint damage. Because they take several weeks or months to show clinical efficacy, short-term corticosteroids are often co-administered for rapid bridging anti-inflammatory control. Read more
Why is routine laboratory monitoring essential during rheumatoid arthritis follow-up?
Continuous laboratory monitoring is critical to assess therapeutic response using inflammatory markers like CRP or ESR, and to identify drug-induced toxicities early. Routine complete blood counts, liver function tests, and renal function panels are standard clinical parameters monitored to safeguard patients on DMARDs. Read more
